Roberto Ferrara

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Epidermal Growth Factor Receptor

Combination Therapy

Ejection Fraction

Top Venues

Future oncology (London, England)

The Journal of experimental medicine

Exploration of targeted anti-tumor therapy

Gustave Roussy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Gustave Roussy Nov 01 2016

France

MD :: Thoracic Oncology Unit

Publications

Emma Zattarin, Sara Manglaviti, Giulia Apollonio, Teresa Beninato, Laura Mazzeo, Giacomo Massa, Achille Bottiglieri, Edoardogregorio Galli, Alessandro De Toma, Mario Occhipinti, Marta Brambilla, Roberto Ferrara, Monica Ganzinelli, Claudia Proto, Marina Chiara Garassino, Filippo de Braud, Giuseppe Lo Russo, Arsela Prelaj
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy. Future oncology (London, England) 18 (23) (2022)
Roberto Ferrara, Luca Roz
Eating away T cell responses in lung cancer. The Journal of experimental medicine 219 (12) (2022)
Marta Brambilla, Giuseppe Lo Russo, Roberto Ferrara, Sara Manglaviti, Marina Chiara Garassino, Mario Alberto Occhipinti
Is hyperprogressive disease a specific phenomenom of immunotherapy? Exploration of targeted anti-tumor therapy 1 (6) (2020)
Roberto Ferrara, Ignacio Matos
Atypical patterns of response and progression in the era of immunotherapy combinations. Future oncology (London, England) 16 (23) (2020)